Dr. Berry is a nationally recognized thought leader in molecular pathology, genomics and laboratory medicine. Since 2014, she has served as the Deputy Director for Molecular Pathology and Genomics, and as the Scientific Director for the Personalized Medicine Program at the Swedish Cancer Institute in Seattle. Since 2014, she has also served as Director of Genomics Programs at CellNetix Pathology and Laboratories. Dr. Berry has board certifications in anatomic pathology and clinical pathology, cytopathology, and molecular genetic pathology. She has participated in a range of impactful roles relating to her expertise, including committees and working groups, nationally and internationally.